Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » 2020 LAIV Influenza Vaccine Approved in China

2020 LAIV Influenza Vaccine Approved in China February 28, 2020 • Category • Author Name

Read the announcement: LAIV Influenza Vaccine Approved in China Melbourne

Latest News

BioDiem Half Year Announcement

April 1, 2021

Half Year Results Announcement

Read More
BioDiem Half Year Report

April 1, 2021

BioDiem Half Year Report

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions